Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

March 10, 2017

Advaxis to Provide Updates on Cervical Cancer Trial Program at Research Reception

News

Advaxis will host a research reception at the Society of Gynecologic Oncology’s 48th Annual Meeting on Women’s Cancer to provide an overview and updates of its cervical cancer clinical trial program. According ... Read more

February 22, 2017

New Model for Cervical Cancer Care in Botswana Cuts Treatment Delays by More Than Half

News

Multidisciplinary team clinics in low- and middle-income countries are realistic and can help reduce delays in cervical cancer treatment, as demonstrated by a new model of cervical cancer care implemented in Botswana. ... Read more

February 6, 2017February 13, 2017

FDA OKs Elekta’s Venezia Brachytherapy Applicator for Cervical Cancer Treatment

News

U.S. regulators have approved the Venezia applicator for treating advanced-stage cervical cancer, according to the device’s maker, Elekta. The Food and Drug Administration‘s (FDA’s) 510(k) clearance means the applicator can be marketed in the United States. The ... Read more

January 20, 2017

Cervical Cancer Vaccination, Screening Highly Encouraged by U of Kentucky Gynecologist

News

Cervical cancer is preventable through vaccination and screening, and people need to be aware of the importance of regular health checks. This is especially important in states like Kentucky, which ... Read more

January 16, 2017

Many Women with Advanced Kidney Disease Aren’t Getting Breast, Cervical Cancer Screening

News

Many women with advanced chronic kidney disease (CKD) may be skipping the breast and cervical cancer screening they need, even though they are at higher risk of developing cancer, according to new ... Read more

November 18, 2016

Genexine, Merck Collaborate to Assess Therapy Combo in HPV-induced Cervical Cancer

News

Genexine and Merck (MSD) are collaborating to evaluate Genexine’s HPV DNA vaccine GX-188E in combination with Keytruda (pembrolizumab) as a potential treatment for patients with HPV-induced cancers. Under the terms of the agreement, Genexine ... Read more

November 14, 2016

Early Trial Data of Axal Combo Therapy for HPV-linked Cervical Cancer Presented by Advaxis

News

Advaxis recently presented new data demonstrating the clinical benefit of Axal, its lead immunotherapy candidate, both as a single therapy and in combination with other immunotherapies, for patients with HPV-associated cervical cancer. ... Read more

November 9, 2016

Advaxis Begins Phase 3 Study of AXAL for Advanced Cervical Cancer

News

Advaxis has begun its Phase 3 clinical trial evaluating axalimogene filolisbac, or AXAL, administered in the adjuvant setting following chemotherapy and radiation in women with high-risk, locally advanced cervical cancer. ... Read more

October 5, 2016October 5, 2016

Young Cervical Cancer Survivors Among Those Consuming More Sugar-Sweetened Drinks

News

Age may play a role when considering the link between cancer and sugar-sweetened beverages, a new LSU Health New Orleans study found, suggesting that intervention programs aiming to reduce consumption of ... Read more

September 14, 2016September 14, 2016

Europe Seen to Have Least Confidence in Vaccine Safety in Global Survey

News

Public confidence in vaccines diverges between countries and world regions, with Europe being the region most distrustful of vaccine safety, according to the results of the largest global survey of confidence in vaccines published in ... Read more